Cargando…

Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver

Mostrar otras versiones (1)

Transgenic mice overexpressing growth hormone (GH) spontaneously develop liver tumors, including hepatocellular carcinoma (HCC), within a year. The preneoplastic liver pathology in these mice recapitulates that observed in humans at high risk of developing hepatic cancer. Although increased expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacigalupo, María L, Piazza, Verónica G, Cicconi, Nadia S, Carabias, Pablo, Bartke, Andrzej, Fang, Yimin, Sotelo, Ana I, Rabinovich, Gabriel A, Troncoso, María F, Miquet, Johanna G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652241/ https://www.ncbi.nlm.nih.gov/pubmed/31272083 http://dx.doi.org/10.1530/EC-19-0292

Ejemplares similares

Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver
por: Bacigalupo, María L, et al.
Publicado: (2021)

Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression
por: Bacigalupo, María L, et al.
Publicado: (2017)

Analysis of Different Approaches for the Selection of Reference Genes in RT-qPCR Experiments: A Case Study in Skeletal Muscle of Growing Mice
por: Piazza, Verónica G., et al.
Publicado: (2017)

Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression
por: Carabias, Pablo, et al.
Publicado: (2022)

MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
por: Espelt, María V, et al.
Publicado: (2019)

The universe of galectin-binding partners and their functions in health and disease
por: Troncoso, María F., et al.
Publicado: (2023)

Long‐lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high‐fat diet on metabolic function and energy expenditure
por: Hill, Cristal M., et al.
Publicado: (2016)

Resistance to the Beneficial Metabolic Effects and Hepatic Antioxidant Defense Actions of Fibroblast Growth Factor 21 Treatment in Growth Hormone-Overexpressing Transgenic Mice
por: Boparai, Ravneet K., et al.
Publicado: (2015)

Alterations in oxidative, inflammatory and apoptotic events in short-lived and long-lived mice testes
por: Matzkin, María Eugenia, et al.
Publicado: (2016)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Transcriptional upregulation of galectin-3 in multiple sclerosis
por: Mangano, Katia, et al.
Publicado: (2023)

Pro-tumorigenic roles of TGF-β signaling during the early stages of liver tumorigenesis through upregulation of Snail
por: Moon, Hyuk, et al.
Publicado: (2017)

Pro‐tumorigenic role of ERα in prostate cancer cells
por: Furic, Luc, et al.
Publicado: (2015)

Therapeutic yoga reduces pro-tumorigenic cytokines in cancer survivors
por: Patel, Darpan I., et al.
Publicado: (2022)

CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic
por: Marshall, A D, et al.
Publicado: (2017)

“Galectin-1 Induces Central and Peripheral Cell Death: Implications in T-Cell Physiopathology”
por: Sotomayor, C. E., et al.
Publicado: (2000)

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019)

A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins
por: Farhadi, Shaheen A., et al.
Publicado: (2020)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer
por: Anderson, Ronald, et al.
Publicado: (2023)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Decellularized Matrix from Tumorigenic Human Mesenchymal Stem Cells Promotes Neovascularization with Galectin-1 Dependent Endothelial Interaction
por: Burns, Jorge S., et al.
Publicado: (2011)

Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
por: Chung, Ling-Yen, et al.
Publicado: (2014)

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2013)

Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients
por: Sundblad, Victoria, et al.
Publicado: (2018)

Suppression of Cell Tumorigenicity by Non-neural Pro-differentiation Factors via Inhibition of Neural Property in Tumorigenic Cells
por: Yang, Xiaoli, et al.
Publicado: (2021)

ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts
por: Al-Ansari, Mysoon M., et al.
Publicado: (2018)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
por: Mendez-Huergo, Santiago P., et al.
Publicado: (2019)

COX-2 MEDIATES PRO-TUMORIGENIC EFFECTS OF PKCε IN PROSTATE CANCER
por: Garg, Rachana, et al.
Publicado: (2018)

Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology
por: Pérez, Cecilia V., et al.
Publicado: (2015)

A Pro-resolving Role for Galectin-1 in Acute Inflammation
por: Law, Hannah L., et al.
Publicado: (2020)

Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
por: Etulain, Julia, et al.
Publicado: (2014)

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer
por: Kourtidis, Antonis, et al.
Publicado: (2015)

CTHRC1 activates pro-tumorigenic signaling pathways in hepatocellular carcinoma
por: Wang, Yunpeng, et al.
Publicado: (2017)

Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
por: Puré, Ellen, et al.
Publicado: (2018)

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue
por: Franzè, Eleonora, et al.
Publicado: (2017)

Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
por: Jakhar, Rekha, et al.
Publicado: (2019)

Mutant p53 elicits context-dependent pro-tumorigenic phenotypes
por: McCann, Jennifer J., et al.
Publicado: (2021)

The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4uec5a5cef4b0jlmjbqunoous1